Pedro Cano
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Papers in
- Hematology 30
- Hematopoietic Stem Cell Transplantation 26
- Blood groups and transfusion 3
-
- Renal Transplantation Outcomes and Treatments 7
- Co-authors
- Marcelo Fernández-Viña (33 shared papers)Richard E. Champlin (19 shared papers)Marcos J. G. De Lima (17 shared papers)Elizabeth J. Shpall (13 shared papers)Sergio A. Giralt (16 shared papers)Stefan Octavian Ciurea (8 shared papers)Xuemei Wang (2 shared papers)Peter F. Thall (3 shared papers)
- Journals
- Human Immunology (14 papers)Blood (13 papers)Transplantation and Cellular Therapy (4 papers)Cancer Immunology Immunotherapy (2 papers)BMC Cancer (1 paper)
- Partner nations
- United StatesLebanonBrazil
In The Last Decade
Pedro Cano
50 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 67
- Hematology 1k
- Transplantation 251
- Genetics 306
- Immunology 105
- Gastroenterology 29
Countries citing papers authored by Pedro Cano
This map shows the geographic impact of Pedro Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Cano more than expected).
Fields of papers citing papers by Pedro Cano
This network shows the impact of papers produced by Pedro Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Cano. The network helps show where Pedro Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 228 | |
| 2 | 2013 | 199 | |
| 3 | 2007 | 192 | |
| 4 | 2011 | 175 | |
| 5 | 2003 | 160 | |
| 6 | 2013 | 132 | |
| 7 | 2012 | 77 | |
| 8 | 2009 | 70 | |
| 9 | 2009 | 53 | |
| 10 | 2005 | 46 | |
| 11 | 2011 | 39 | |
| 12 | 2009 | 34 | |
| 13 | 2009 | 34 | |
| 14 | 2007 | 31 | |
| 15 | 2011 | 28 | |
| 16 | 2010 | 23 | |
| 17 | 2018 | 22 | |
| 18 | 2004 | 21 | |
| 19 | 1998 | 20 | |
| 20 | 2010 | 20 |
About Pedro Cano
Pedro Cano is a scholar working on Hematology, Transplantation, Immunology, Genetics and Molecular Biology, having authored 53 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (26 papers), vaccines and immunoinformatics approaches (9 papers), Genetic Associations and Epidemiology (7 papers), Renal Transplantation Outcomes and Treatments (7 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers), Blood groups and transfusion (3 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Hematology (1k citations), Transplantation (251 citations), Genetics (306 citations), Immunology (105 citations) and Gastroenterology (29 citations). Pedro Cano has collaborated with scholars based in United States, Lebanon and Brazil. Frequent co-authors include Marcelo Fernández-Viña, Richard E. Champlin, Marcos J. G. De Lima, Elizabeth J. Shpall, Sergio A. Giralt, Stefan Octavian Ciurea, Xuemei Wang, Peter F. Thall, Martin J. Korbling and Michelle I. Setterholm. Their work appears in journals such as Human Immunology, Blood, Transplantation and Cellular Therapy, Cancer Immunology Immunotherapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.